17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells

Plasma levels of PCSK9 are significantly higher in postmenopausal women. Pharmacologically increased estrogen levels have been shown to lower PCSK9 and LDL-C levels in animals and humans. The action of estrogen suggests that it has the ability to prevent PCSK9-mediated LDLR degradation in liver cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Wei, Gao, Xiao-Ping, Zhang, Sheng, Dai, Yan-Ping, Zou, Wen-Jun, Yue, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002320/
https://www.ncbi.nlm.nih.gov/pubmed/32082252
http://dx.doi.org/10.3389/fendo.2019.00930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002320/
https://www.ncbi.nlm.nih.gov/pubmed/32082252
http://dx.doi.org/10.3389/fendo.2019.00930

Ejemplares similares